Gastrointestinal Tumor Clinical Trials

5 recruiting

Gastrointestinal Tumor Trials at a Glance

14 actively recruiting trials for gastrointestinal tumor are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Phase 1 with 5 trials, with the heaviest enrollment activity in Beijing, Shanghai, and Chengdu. Lead sponsors running gastrointestinal tumor studies include Sichuan Baili Pharmaceutical Co., Ltd., Huashan Hospital, and Changhai Hospital.

Browse gastrointestinal tumor trials by phase

Treatments under study

About Gastrointestinal Tumor Clinical Trials

Looking for clinical trials for Gastrointestinal Tumor? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastrointestinal Tumor trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastrointestinal Tumor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 2

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting

GISTGIST - Gastrointestinal Stromal TumorGastrointestinal Tumors+2 more
Kumquat Biosciences Inc.46 enrolled1 locationNCT07406633
Recruiting
Phase 2

Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors

Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors
Changhai Hospital40 enrolled1 locationNCT07492693
Recruiting
Phase 1

A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Solid TumorsGastrointestinal Tumors
Sichuan Baili Pharmaceutical Co., Ltd.33 enrolled1 locationNCT07279428
Recruiting
Phase 1

A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Solid TumorsGastrointestinal Tumors
Sichuan Baili Pharmaceutical Co., Ltd.22 enrolled1 locationNCT07232407
Recruiting
Early Phase 1

A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)

Gastrointestinal Tumor
Shanghai Juncell Therapeutics50 enrolled1 locationNCT04960072
Recruiting
Phase 1

A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor

Gastrointestinal Tumor
Sichuan Baili Pharmaceutical Co., Ltd.96 enrolled6 locationsNCT05262491
Recruiting
Phase 1

Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment

Gastrointestinal TumorsPersonalized Neoantigen Vaccine in Combination With Anti-PD-1 Inhibitors in Standard Therapy-Failed and Adjuvant Therapy
Ruijin Hospital40 enrolled1 locationNCT07067385
Recruiting
Phase 1

A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Solid TumorGastrointestinal Tumor
Sichuan Baili Pharmaceutical Co., Ltd.45 enrolled1 locationNCT06954077
Recruiting
Not Applicable

REmote Symptom COllection to improVE postopeRative Care

Gastrointestinal CancerGastrointestinal TumorGastrointestinal Tumor Surgery
Medstar Health Research Institute281 enrolled2 locationsNCT06190730
Recruiting

Combined Screening for Gastrointestinal Tumors

Gastrointestinal Tumors
Zhejiang Cancer Hospital200,000 enrolled2 locationsNCT06478030
Recruiting
Phase 2

The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors

Gastrointestinal Tumors
Huashan Hospital40 enrolled1 locationNCT06775080
Recruiting
Not Applicable

PD-L1 Targeting Molecular Imaging of Solid Tumors

Gastrointestinal Tumors
Peking University Cancer Hospital & Institute20 enrolled1 locationNCT04629326
Recruiting
Not Applicable

EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope

Pancreatic CancerGastrointestinal CancerBile Duct Cancer+6 more
Orlando Health, Inc.140 enrolled1 locationNCT06340620
Recruiting
Early Phase 1

BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors

Gastrointestinal Tumors
BioSyngen Pte Ltd14 enrolled1 locationNCT06152757